Literature DB >> 8760802

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

M A Alexander-Miller1, G R Leggatt, A Sarin, J A Berzofsky.   

Abstract

Experimental data suggest that negative selection of thymocytes can occur as a result of supraoptimal antigenic stimulation. It is unknown, however, whether such mechanisms are at work in mature CD8+ T lymphocytes. Here, we show that CD8+ effector cytotoxic T lymphocytes (CTL) are susceptible to proliferative inhibition by high dose peptide antigen, leading to apoptotic death mediated by TNF-alpha release. Such inhibition is not reflected in the cytolytic potential of the CTL, since concentrations of antigen that are inhibitory for proliferation promote efficient lysis of target cells. Thus, although CTL have committed to the apoptotic pathway, the kinetics of this process are such that CTL function can occur before death of the CTL. The concentration of antigen required for inhibition is a function of the CTL avidity, in that concentrations of antigen capable of completely inhibiting high avidity CTL maximally stimulate low avidity CTL. Importantly, the inhibition can be detected in both activated and resting CTL. Blocking studies demonstrate that the CD8 molecule contributes significantly to the inhibitory signal as the addition of anti-CD8 antibody restores the proliferative response. Thus, our data support the model that mature CD8+ CTL can accommodate an activation signal of restricted intensity, which, if surpassed, results in deletion of that cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760802      PMCID: PMC2192715          DOI: 10.1084/jem.184.2.485

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death.

Authors:  D S Ucker; J Meyers; P S Obermiller
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

2.  Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation.

Authors:  K Wieties; R E Hammer; S Jones-Youngblood; J Forman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  Antigen-induced suppression of the proliferative response of T cell clones.

Authors:  G Suzuki; Y Kawase; S Koyasu; I Yahara; Y Kobayashi; R H Schwartz
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

5.  Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes.

Authors:  A Vitiello; W R Heath; L A Sherman
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

6.  CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.

Authors:  G Pantaleo; A De Maria; S Koenig; L Butini; B Moss; M Baseler; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Antigen as a positive and negative regulator of proliferation in cytotoxic lymphocytes. A model for the differential regulation of proliferation and lytic activity.

Authors:  J H Russell; D E Manning; D E McCulley; P Meleedy-Rey
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

8.  Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen.

Authors:  M K Newell; L J Haughn; C R Maroun; M H Julius
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

9.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Authors:  H Takahashi; J Cohen; A Hosmalin; K B Cease; R Houghten; J L Cornette; C DeLisi; B Moss; R N Germain; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 10.  The thymus selects the useful, neglects the useless and destroys the harmful.

Authors:  H von Boehmer; H S Teh; P Kisielow
Journal:  Immunol Today       Date:  1989-02
View more
  59 in total

Review 1.  Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

Authors:  William Y Ho; Cassian Yee; Philip D Greenberg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

Authors:  SangKon Oh; Liyanage P Perera; Donald S Burke; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

3.  Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.

Authors:  Ling Ni; Ingrid Gayet; Sandra Zurawski; Dorothee Duluc; Anne-Laure Flamar; Xiao-Hua Li; Amy O'Bar; Sandra Clayton; Anna Karolina Palucka; Gerard Zurawski; Jacques Banchereau; SangKon Oh
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

Review 4.  High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors.

Authors:  Martha A Alexander-Miller
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

Authors:  Matthias Leisegang; Susanne Wilde; Stefani Spranger; Slavoljub Milosevic; Bernhard Frankenberger; Wolfgang Uckert; Dolores J Schendel
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

6.  Memory generation and maintenance of CD8+ T cell function during viral persistence.

Authors:  Stephanie S Cush; Kathleen M Anderson; David H Ravneberg; Janet L Weslow-Schmidt; Emilio Flaño
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes.

Authors:  J Wan; D Martinvalet; X Ji; C Lois; S M Kaech; U H Von Andrian; J Lieberman; R Ahmed; N Manjunath
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

8.  In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Authors:  Beth C Holbrook; Rama D Yammani; Lance K Blevins; Martha A Alexander-Miller
Journal:  Viral Immunol       Date:  2013-08-24       Impact factor: 2.257

9.  Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer.

Authors:  James L Gulley; Ravi A Madan; Kwong Y Tsang; Caroline Jochems; Jennifer L Marté; Benedetto Farsaci; Jo A Tucker; James W Hodge; David J Liewehr; Seth M Steinberg; Christopher R Heery; Jeffrey Schlom
Journal:  Cancer Immunol Res       Date:  2013-11-04       Impact factor: 11.151

Review 10.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.